Filing Details
- Accession Number:
- 0001214659-25-004592
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-20 16:30:07
- Reporting Period:
- 2025-03-20
- Filing Date:
- 2025-03-20
- Accepted Time:
- 2025-03-20 16:30:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1677077 | Alzamend Neuro Inc. | ALZN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1333268 | B. William Horne | 3480 Peachtree Road Ne Second Floor, Suite 103 Atlanta GA 30326 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-20 | 5,000 | $0.98 | 26,666 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.9783. The range of purchase prices on the transaction date was $0.974 to $0.9799 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
Billionaire Hedge Funds
